Pharm Flashcards

(35 cards)

1
Q

what is the combination treatment for ALL (combination tx is used b/c of resistance)

A

vincristine + prednisone + ________ (6-MP, cyclophosphamide, or daunorubicin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most active agent for AML

A

cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

best combo tx for AML

A

cytarabine + idarubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

combo tx for AML is followed by ______

A

high-dose chemo and total body irradiation followed by immunosuprression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 first line treatments for chronic phase CML

A

imatibin, dasatibin, nilotinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

besides the first line tx for CML imatibin, dasatibin, nilotinib, what other drug can be used

A

busulfan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

two regimens for CLL

A

COP: cyclophosphamide + vincristine + prednisone

CHOP: cyclophosphamide + vincristine + prednisone + doxorubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

besides COP and CHOP, what agents can be used for CLL

A

bendamustine (monotherapy or w/ prednisone)

fludarabine (monotherapy or w/ cyclophosphamide and mitoxantrone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

regimen for hodgkin’s lymphoma stage I and IIa

A

ABVD - doxorubicin, bleomycin, vinblastine, dacarbazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

regimen for hodgkin’s lymphoma stage III and IV

A

MOPP: mechlorethamine, vincristine, procarbazine, prednisone

ABVD: doxorubicin, bleomycin, vinblastine, dacarbazine

Stanford V: doxorubicin, vinblastine, mechlorethamine, vincristine, bleomycin, etoposide, prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

compare MOPP, ABVD, and stanford V regimens for hodgkin’s lymphoma III and IV

A

ABVD: more effective and less toxic than MOPP

stanford V: middle best

MOPP: most adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

regimen for diffuse non-hodgkin’s lymphoma

A

CHOP: cyclophosphamide, doxorubicin, vincristine, prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

regimen for nodular (follicular) non-hodgkin’s lymphoma

A

bendamustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

regimen for multiple myeloma

A

melphalan + prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treatment for stage 1 breast cancer

A

surgery alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treatment for stage 2 breast cancer

A

post-operative:

CMF: cyclophosphamide, methotrexate, 5-FU

FAC: 5-FU, doxorubicin, cyclophosphamide

17
Q

treatment for hormone refractory prostate CA

A

docetaxel + prednisone

18
Q

regimens for high risk stage II and III colorectal CA

A

FOLFOX: leucovorin + 5-FU + oxaliplatin

XELOX: capecitabine + oxaliplatin

19
Q

regimens for metastatic colorectal cancer

A

FOLFIRI: leucovorin + 5-FU + irinotecan

FOLFIRI or FOLFOX + bevacizumab or cetuximab/panitumumab

20
Q

what agent do you use for chemo-refractory setting of colorectal cancer

21
Q

standard treatment for non-small cell lung CA with non-squamous histology

A

bevacizumab + carboplatin + paclitaxel

22
Q

treatment for non-small cell lung CA with squamous cell histology

A

cisplatin or carboplatin + cetuximab

23
Q

agent used for maintenance chemotherapy in non-small cell lung CA

24
Q

targeted therapy for non-small cell lung CA pts with sensitizing EGFR mutations

first line tx for metastatic NSCLC w/ EGFR mutations

tx for metastatic NSCLC w/ EGFR T790 mutations

A

erlotinib

afatinib

osimertinib

25
what agent is used in NSCLC that has progressed or after standard platinum-based chemo
nivolumab
26
regimen for small cell lung cancer
cisplatin + etoposide or cisplatin + irinotecan
27
what is used as second line monotherapy in small cell lung CA pts that failed platinum based regimen
topotecan
28
tx for stage 1 ovarian CA
cisplatin and cyclophosphamide
29
tx for stage III and IV ovarian CA
carboplatin and paclitaxel
30
tx for recurrent dz of ovarian CA
topotecan or liposomal doxorubicin
31
tx testicular CA
PEB: cisplatin + etoposide + bleomycin
32
tx metastatic malignant melanoma
dacarbazine and cisplatin
33
tx for unresectable or metastatic melanoma as monotherapy
nivolumab or pembrolizumab
34
monotherapy and regmin tx brain cancer
monotherapy: carmustine regimen: PCV: procarbazine + vincristine
35
tx for adult glioblastoma multiforme
bevacizumab